Keywords: fda, panel, recommends, anti-epileptics, get, strong, warning

FDA panel recommends anti-epileptics should not get strong warning on suicide risk

Article | 21 July 2008

Print This

A panel of outside experts convened by the US Food and Drug Administration has concluded that epilepsy drugs do not ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in